Molybdenum (Mo, Sodium Molybdate, Ammonium Molybdate)

 

Other Contra-Indication

Our Records are Incomplete for Other Contra-Indications

 

Class Contra-Indication

Our Records are Incomplete for Drug Class Contra-Indications

We have incomplete side-effect data.

Erectile Dysfunction:

Recommendation: No recommendation (There is insufficient evidence to support claims that Molybdenum has any affect on the treatment of erectile dysfunction)

Grade of Evidence: Very low level of evidence 


Anaemia:

Recommendation: No recommendation (There is insufficient evidence to support claims that Molybdenum has any affect on the treatment of anaemia)

Grade of Evidence: Very low level of evidence 


Breast Cancer:

Recommendation: Weakly in favor (Laboratory studies show that breast cancer may respond to Molybdenum, however more research on human subjects is needed)

Grade of Evidence: Very low level of evidence 


Gout:

Recommendation: No recommendation (There is insufficient evidence to support claims that Molybdenum has any affect on the treatment of gout)

Grade of Evidence: Very low level of evidence 


Iron Deficiency Anemia:

Recommendation: No recommendation (There is insufficient evidence to support claims that Molybdenum has any affect on the treatment of anaemia)

Grade of Evidence: Very low level of evidence 


Male Sexual Dysfunction:

Recommendation: No recommendation (There is insufficient evidence to support claims that Molybdenum has any affect on the treatment of sexual dysfunction)

Grade of Evidence: Very low level of evidence 


Tooth Infection:

Recommendation: No recommendation (There is insufficient evidence to support claims that Molybdenum has any affect on the treatment of anaemia)

Grade of Evidence: Very low level of evidence 


Anaemia of Chronic Disease:

Recommendation: No recommendation (There is insufficient evidence to support claims that Molybdenum has any affect on the treatment of anaemia)

Grade of Evidence: Very low level of evidence 


Anaemia of Chronic Renal Failure

Recommendation: No recommendation (There is insufficient evidence to support claims that Molybdenum has any affect on the treatment of anaemia)

Grade of Evidence: Very low level of evidence 


Kidney Cancer:

Recommendation: Weakly in favor (Laboratory studies show that kidney cancer may respond to Molybdenum, however more research on human subjects is needed)

Grade of Evidence: Very low level of evidence 


References: 
1. Ades T, Alteri R, Gansler T, Yeargin P, "Complete Guide to Complimentary & Alternative Cancer Therapies", American Cancer Society, Atlanta USA, 2009

2. http://lpi.oregonstate.edu/infocenter/minerals/molybdenum/

3. Hassouneh B, Islam M, Nagel T, Pan Q, Merajver SD, Teknos TN. Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer. Mol Cancer Ther. 2007;6:1039-1045.

4. Cassileth B. The Alternative Medicine Handbook: The Complete Reference Guide to Alternative and Complementary Therapies. New York, NY: W.W. Norton; 1998.

5. Nakadaira H, Endoh K, Yamamoto M, Katoh K. Distribution of selenium and molybdenum and cancer mortality in Niigata, Japan. Arch Environ Health. 1995;50:374-380.

Public Discussion